2025年全球醫藥品管市場報告

近年來，藥品品管市場發展迅速，從2024年的82.3億美元成長到2025年的90.8億美元，複合年成長率達10.4%。這段時期的成長主要受以下因素驅動：藥品研發投入增加、藥品召回事件增加、藥品安全意識提高、合規性主導的檢測通訊協定擴展以及藥品國際貿易成長。

預計未來幾年，醫藥品管市場將快速成長，到2029年市場規模將達到132.9億美元，複合年成長率（CAGR）為10.0%。推動年複合成長率期內市場成長的因素包括：人工智慧在品管流程中的應用日益廣泛、對精準醫療檢測的需求不斷成長、對高品質藥品的需求持續擴大、契約製造服務不斷拓展以及對即時品質監控系統的日益重視。這段時期的主要趨勢包括：基於人工智慧的視覺檢測系統的發展、利用生物感測器的創新微生物檢測技術、雲端基礎的品管平台的開發、即時環境監測系統的創新以及用於過程模擬的數位雙胞胎技術的進步。

藥品品管（QC）是一個結構化的流程，旨在檢驗藥品的特性、效價、純度和一致性。原料、中間產品和成品都經過嚴格檢驗，以確保其符合既定標準，從而在藥品到達患者手中之前保證其安全性和有效性。

關鍵的藥品品管產品包括耗材、服務和設備。品質控制耗材包括培養基、試劑、檢測試劑套件、過濾器和微量吸管尖，這些都是實驗室檢測中維持藥品品質、安全性和合規性所必需的材料和耗材。這些耗材可以透過雲端基礎、網路或本地部署的方式進行部署。分析流程包括無菌檢測、薄膜過濾、直接接種、微生物附著量檢測、需氧菌和厭氧菌計數、孢子計數、真菌和黴菌計數以及內毒素檢測。藥品品質控制產品和服務被製藥和生物技術公司、受託製造廠商(CDMO)、委外研發機構(CRO) 以及研究實驗室廣泛使用。

美國在2025年春季突然提高關稅及其引發的貿易摩擦對製藥公司造成了嚴重衝擊。利潤豐厚的學名藥生產商尤其脆弱，一些公司不得不縮減低收益藥物的生產規模。生物技術公司也因關稅導致的專用試劑短缺而面臨臨床試驗延期。為因應這一局面，製藥業正在印度和歐洲擴大原料藥的生產，增加庫存，並遊說政府對基本藥物給予貿易豁免。

這份醫藥品管市場研究報告是商業研究公司最新發布的系列報告之一，提供醫藥品管市場統計數據，例如全球市場規模、區域佔有率、市場佔有率競爭對手、詳細的市場細分、市場趨勢以及醫藥品管品管行業的商機。這份醫藥品管品管研究報告全面概​​述了您所需的一切資訊，並對該行業的現狀和未來發展趨勢進行了深入分析。

生物相似藥需求的成長預計將推動藥品品管市場的發展。生物相似藥是指與核准的參考生物製藥高度相似，但在安全性、純度或效力方面無臨床意義差異的生物製藥製品。由於原廠生物生物製藥的專利到期，使得價格更實惠的替代產品得以進入市場，因此對生物相似藥的需求不斷成長。藥品品管在確保生物相似藥符合嚴格的安全性、純度和一致性標準方面發揮著至關重要的作用，它透過與參考生技藥品進行嚴格的比較，支持監管合規和市場核准。例如，美國醫療保健公司康德樂（Cardinal Health）報告稱，美國FDA核准的生物相似藥數量從2022年1月的33種（其中21種已上市）增加到2023年的40種（其中25種已上市）。這一趨勢凸顯了生物相似藥生產中對品管解決方案日益成長的需求。

製藥品管市場的企業正擴大採用人工智慧驅動的軟體平台等技術創新，以提高檢測的準確性、效率和合規性。智慧軟體平台利用自動化、數據分析和人工智慧技術，檢測整個製藥生產過程中的異常情況，監控即時數據，並簡化合規流程。例如，2025年6月，印度Dycine Pharmaceuticals Ltd.推出了一款人工智慧主導的品管平台，該平台利用預測分析、自動報告以及與現有生產系統的無縫整合，來減少錯誤、提高效率並確保各生產批次產品品質的一致性。

2024年10月，美國藥典委員會（USP）—一家位於美國的獨立科學組織—收購了先進微生物檢測解決方案供應商Stratix Labs。此次收購將使USP能夠擴展其微生物檢測和污染控制能力，降低微生物污染風險，並彌補其藥品污染控制策略中的不足。

醫藥品管市場由提供分析檢測服務、微生物檢測服務、穩定性檢測服務、無菌保證服務、以及驗證和資格確認服務等服務的營業單位所獲得的收益所構成。市場價值包括服務提供者銷售的或包含在服務範圍內的相關商品的價值。醫藥品管市場還包括試劑和檢測試劑套件、過濾器和膜、無菌檢測系統、層析管柱和耗材的銷售。換言之，它是商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球藥品品管：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 終端用戶產業分析
• 全球醫藥品管市場：成長率分析
• 全球醫藥品管市場表現：規模與成長，2019-2024年
• 全球醫藥品管市場預測：規模與成長，2024-2029年，2034年
• 全球藥品品管：潛在市場規模 (TAM)

第6章 市場細分

• 全球藥品品管市場：依產品、性能及預測分類，2019-2024年、2024-2029年、2034年
• 消耗品
• 服務
• 裝置
• 全球醫藥品管市場依部署類型、性能及預測分類，2019-2024年、2024-2029年、2034年
• 雲端基礎和網路為基礎的
• 本地部署
• 全球藥品品管市場分析類型：績效與預測，2019-2024年、2024-2029、2034年
• 無菌測試
• 薄膜過濾
• 直接接種
• 生物污染測試
• 需氣菌計數測試
• 厭氧菌計數測試
• 孢子計數測試
• 真菌或黴菌數量檢測
• 內毒素檢測
• 其他分析類型
• 全球醫藥品管市場（依最終使用者、效能和預測分類，2019-2024年、2024-2029年、2034年）
• 製藥和生物技術公司
• 合約開發和製造組織或合約研究組織
• 實驗室
• 全球藥品品管市場：按耗材（類型）細分、性能及預測，2019-2024年、2024-2029年、2034年
• 培養基
• 試劑
• 檢測套件
• 過濾器和薄膜
• 微量吸管尖
• 全球藥品品管市場：依服務類型、績效及預測細分，2019-2024年、2024-2029年、2034年
• 微生物檢測服務
• 分析測試服務
• 穩定性測試服務
• 無菌保證服務
• 檢驗和合格服務
• 全球藥品品管市場：按設備類型、性能和預測進行細分，2019-2024年、2024-2029年、2034年
• 層析法系統
• 光譜設備
• 粒度分析儀
• pH計和電導率儀
• 高壓釜和培養箱

第7章 區域和國家分析

• 全球藥品品管市場：依地區、績效及預測分類，2019-2024年、2024-2029年、2034年
• 全球藥品品管市場：按國家、績效和預測分類，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 醫藥品管市場：競爭格局
• 醫藥品管市場：公司概況
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• McKinsey And Company Inc.
• SGS SA
• Eurofins Scientific SE
• WuXi AppTec Co. Ltd.
• Charles River Laboratories International Inc.
• PerkinElmer Inc.
• Mettler-Toledo International Inc.
• bioMerieux SA
• Shimadzu Scientific Instruments Inc.
• Waters Corporation
• Randox Laboratories Ltd.
• SOLVIAS AG
• Esco Micro Pte. Ltd
• REMI Elektrotechnik Limited
• Lucideon Limited

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

• 2029年醫藥品管市場：提供新機會的國家
• 2029年醫藥品管市場：新興細分市場機會
• 2029年醫藥品管市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章附錄

Pharmaceutical quality control (QC) is a structured process designed to verify the identity, strength, purity, and consistency of pharmaceutical products. It involves thorough testing of raw materials, in-process samples, and finished products to ensure compliance with established standards, thereby guaranteeing the safety and efficacy of medicines before they reach patients.

The primary products in pharmaceutical quality control include consumables, services, and instruments. QC consumables consist of essential materials and supplies such as culture media, reagents, assay kits, filters, and pipette tips used during laboratory testing to maintain the quality, safety, and regulatory compliance of pharmaceutical products. These consumables can be deployed via cloud-based, web-based, or on-premises methods. The analytical processes include sterility testing, membrane filtration, direct inoculation, bioburden testing, aerobic and anaerobic count testing, spore count testing, fungi or mold count testing, endotoxin testing, and more. Pharmaceutical QC products and services are used by pharmaceutical and biotechnology companies, contract development and manufacturing organizations (CDMOs), contract research organizations (CROs), and research laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The pharmaceutical quality control market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical quality control market statistics, including pharmaceutical quality control industry global market size, regional shares, competitors with a pharmaceutical quality control market share, detailed pharmaceutical quality control market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical quality control industry. This pharmaceutical quality control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical quality control market size has grown rapidly in recent years. It will grow from $8.23 billion in 2024 to $9.08 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth during the historic period can be attributed to increasing investments in pharmaceutical research and development, a rise in drug recall incidents, growing awareness of drug safety, expanded compliance-driven testing protocols, and the rising international trade of pharmaceutical products.

The pharmaceutical quality control market size is expected to see rapid growth in the next few years. It will grow to $13.29 billion in 2029 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to the rising adoption of artificial intelligence in quality control processes, an increasing need for precision medicine testing, growing demand for high-quality pharmaceuticals, expansion of contract manufacturing services, and a heightened focus on real-time quality monitoring systems. Key trends during this period include advancements in AI-powered visual inspection systems, innovative microbial detection technologies using biosensors, development of cloud-based quality control platforms, innovations in real-time environmental monitoring systems, and progress in digital twin technology for process simulation.

The rising demand for biosimilars is expected to drive growth in the pharmaceutical quality control market. Biosimilars are biologic medical products that are highly similar to an approved reference biologic, with no clinically meaningful differences in safety, purity, or potency. The demand for biosimilars is increasing due to patent expirations on original biologics, which allow more affordable alternatives to enter the market. Pharmaceutical quality control plays a critical role in ensuring that biosimilars meet strict safety, purity, and consistency standards by rigorously comparing them against reference biologics, supporting regulatory compliance and market approval. For example, Cardinal Health Inc., a US-based healthcare company, reported that the number of FDA-approved biosimilars in the US rose from 33 in January 2022 (with 21 commercially available) to 40 in 2023, with 25 commercially available. This trend highlights the growing need for quality control solutions in biosimilar production.

Companies in the pharmaceutical quality control market are increasingly adopting technological innovations such as AI-powered software platforms to improve testing accuracy, efficiency, and regulatory compliance. Intelligent software platforms use automation, data analytics, and artificial intelligence to detect anomalies, monitor real-time data, and streamline compliance throughout the pharmaceutical production process. For instance, in June 2025, Dycine Pharmaceuticals Ltd., an India-based company, launched an AI-driven quality control platform that leverages predictive analytics, automated reporting, and seamless integration with existing manufacturing systems to reduce errors, improve efficiency, and ensure consistent product quality across production batches.

In October 2024, the United States Pharmacopeial Convention (USP), a US-based independent scientific organization, acquired Stratix Labs, a provider of advanced microbiological testing solutions. This acquisition enables USP to expand its microbiological testing and contamination control capabilities, reduce microbial contamination risks, and address gaps in pharmaceutical contamination control strategies, thereby ensuring safer, higher-quality products reach patients.

Major players in the pharmaceutical quality control market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, McKinsey And Company Inc., SGS S.A., Eurofins Scientific SE, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Mettler-Toledo International Inc., bioMerieux SA, Shimadzu Scientific Instruments Inc., Waters Corporation, Randox Laboratories Ltd., SOLVIAS AG, Esco Micro Pte. Ltd, REMI Elektrotechnik Limited, Lucideon Limited, and BRAM-COR S.p.A.

North America was the largest region in the pharmaceutical quality control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharmaceutical quality control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharmaceutical quality control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical quality control market consists of revenues earned by entities by providing services such as analytical testing services, microbiological testing services, stability testing services, sterility assurance services, and validation and qualification services. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical quality control market also includes sales of reagents and assay kits, filters and membranes, sterility testing systems, and chromatography columns and consumables. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Quality Control Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical quality control market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical quality control ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical quality control market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Consumables; Services; Instruments
• 2) By Deployment Type: Cloud-Based And Web-Based; On-Premises
• 3) By Analysis Type: Sterility Testing; Membrane Filtration; Direct Inoculation; Bio Burden Testing; Aerobic Count Testing; Anaerobic Count Testing; Spore Count Testing; Fungi or Mold Count Testing; Endotoxin Testing; Other Analysis Types
• 4) By End-user: Pharmaceutical And Biotechnology Companies; Contract Development and Manufacturing Organization Or Contract Research Organization; Research Laboratories
• Subsegments:
• 1) By Consumables: Culture Media; Reagents; Assay Kits; Filters And Membranes; Pipette Tips
• 2) By Services: Microbiological Testing Services; Analytical Testing Services; Stability Testing Services; Sterility Assurance Services; Validation And Qualification Services
• 3) By Instruments: Chromatography Systems; Spectroscopy Instruments; Particle Size Analyzers; Potential Of Hydrogen Meters And Electrical Conductivity Meters; Autoclaves And Incubators
• Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Merck KGaA; Becton, Dickinson and Company; McKinsey And Company Inc.; SGS S.A.; Eurofins Scientific SE; WuXi AppTec Co. Ltd.; Charles River Laboratories International Inc.; PerkinElmer Inc.; Mettler-Toledo International Inc.; bioMerieux SA; Shimadzu Scientific Instruments Inc.; Waters Corporation; Randox Laboratories Ltd.; SOLVIAS AG; Esco Micro Pte. Ltd; REMI Elektrotechnik Limited; Lucideon Limited; BRAM-COR S.p.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Quality Control Market Characteristics

3. Pharmaceutical Quality Control Market Trends And Strategies

4. Pharmaceutical Quality Control Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Pharmaceutical Quality Control Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharmaceutical Quality Control PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharmaceutical Quality Control Market Growth Rate Analysis
• 5.4. Global Pharmaceutical Quality Control Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharmaceutical Quality Control Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharmaceutical Quality Control Total Addressable Market (TAM)

6. Pharmaceutical Quality Control Market Segmentation

• 6.1. Global Pharmaceutical Quality Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consumables
• Services
• Instruments
• 6.2. Global Pharmaceutical Quality Control Market, Segmentation By Deployment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cloud-Based And Web-Based
• On-Premises
• 6.3. Global Pharmaceutical Quality Control Market, Segmentation By Analysis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sterility Testing
• Membrane Filtration
• Direct Inoculation
• Bio Burden Testing
• Aerobic Count Testing
• Anaerobic Count Testing
• Spore Count Testing
• Fungi or Mold Count Testing
• Endotoxin Testing
• Other Analysis Types
• 6.4. Global Pharmaceutical Quality Control Market, Segmentation By Enduser, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Contract Development and Manufacturing Organization Or Contract Research Organization
• Research Laboratories
• 6.5. Global Pharmaceutical Quality Control Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Culture Media
• Reagents
• Assay Kits
• Filters and Membranes
• Pipette Tips
• 6.6. Global Pharmaceutical Quality Control Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microbiological Testing Services
• Analytical Testing Services
• Stability Testing Services
• Sterility Assurance Services
• Validation and Qualification Services
• 6.7. Global Pharmaceutical Quality Control Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chromatography Systems
• Spectroscopy Instruments
• Particle Size Analyzers
• Potential Of Hydrogen Meters and Electrical Conductivity Meters
• Autoclaves and Incubators

7. Pharmaceutical Quality Control Market Regional And Country Analysis

• 7.1. Global Pharmaceutical Quality Control Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharmaceutical Quality Control Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Quality Control Market

• 8.1. Asia-Pacific Pharmaceutical Quality Control Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharmaceutical Quality Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharmaceutical Quality Control Market, Segmentation By Deployment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharmaceutical Quality Control Market, Segmentation By Analysis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Quality Control Market

• 9.1. China Pharmaceutical Quality Control Market Overview
• 9.2. China Pharmaceutical Quality Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharmaceutical Quality Control Market, Segmentation By Deployment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharmaceutical Quality Control Market, Segmentation By Analysis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Quality Control Market

• 10.1. India Pharmaceutical Quality Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharmaceutical Quality Control Market, Segmentation By Deployment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharmaceutical Quality Control Market, Segmentation By Analysis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Quality Control Market

• 11.1. Japan Pharmaceutical Quality Control Market Overview
• 11.2. Japan Pharmaceutical Quality Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharmaceutical Quality Control Market, Segmentation By Deployment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharmaceutical Quality Control Market, Segmentation By Analysis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Quality Control Market

• 12.1. Australia Pharmaceutical Quality Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharmaceutical Quality Control Market, Segmentation By Deployment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharmaceutical Quality Control Market, Segmentation By Analysis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Quality Control Market

• 13.1. Indonesia Pharmaceutical Quality Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharmaceutical Quality Control Market, Segmentation By Deployment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharmaceutical Quality Control Market, Segmentation By Analysis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Quality Control Market

• 14.1. South Korea Pharmaceutical Quality Control Market Overview
• 14.2. South Korea Pharmaceutical Quality Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharmaceutical Quality Control Market, Segmentation By Deployment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharmaceutical Quality Control Market, Segmentation By Analysis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Quality Control Market

• 15.1. Western Europe Pharmaceutical Quality Control Market Overview
• 15.2. Western Europe Pharmaceutical Quality Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pharmaceutical Quality Control Market, Segmentation By Deployment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pharmaceutical Quality Control Market, Segmentation By Analysis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Quality Control Market

• 16.1. UK Pharmaceutical Quality Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pharmaceutical Quality Control Market, Segmentation By Deployment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pharmaceutical Quality Control Market, Segmentation By Analysis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Quality Control Market

• 17.1. Germany Pharmaceutical Quality Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pharmaceutical Quality Control Market, Segmentation By Deployment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pharmaceutical Quality Control Market, Segmentation By Analysis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Quality Control Market

• 18.1. France Pharmaceutical Quality Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pharmaceutical Quality Control Market, Segmentation By Deployment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pharmaceutical Quality Control Market, Segmentation By Analysis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Quality Control Market

• 19.1. Italy Pharmaceutical Quality Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pharmaceutical Quality Control Market, Segmentation By Deployment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pharmaceutical Quality Control Market, Segmentation By Analysis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Quality Control Market

• 20.1. Spain Pharmaceutical Quality Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pharmaceutical Quality Control Market, Segmentation By Deployment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pharmaceutical Quality Control Market, Segmentation By Analysis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Quality Control Market

• 21.1. Eastern Europe Pharmaceutical Quality Control Market Overview
• 21.2. Eastern Europe Pharmaceutical Quality Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pharmaceutical Quality Control Market, Segmentation By Deployment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pharmaceutical Quality Control Market, Segmentation By Analysis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Quality Control Market

• 22.1. Russia Pharmaceutical Quality Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pharmaceutical Quality Control Market, Segmentation By Deployment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pharmaceutical Quality Control Market, Segmentation By Analysis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Quality Control Market

• 23.1. North America Pharmaceutical Quality Control Market Overview
• 23.2. North America Pharmaceutical Quality Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pharmaceutical Quality Control Market, Segmentation By Deployment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pharmaceutical Quality Control Market, Segmentation By Analysis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Quality Control Market

• 24.1. USA Pharmaceutical Quality Control Market Overview
• 24.2. USA Pharmaceutical Quality Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pharmaceutical Quality Control Market, Segmentation By Deployment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pharmaceutical Quality Control Market, Segmentation By Analysis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Quality Control Market

• 25.1. Canada Pharmaceutical Quality Control Market Overview
• 25.2. Canada Pharmaceutical Quality Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pharmaceutical Quality Control Market, Segmentation By Deployment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pharmaceutical Quality Control Market, Segmentation By Analysis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Quality Control Market

• 26.1. South America Pharmaceutical Quality Control Market Overview
• 26.2. South America Pharmaceutical Quality Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pharmaceutical Quality Control Market, Segmentation By Deployment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pharmaceutical Quality Control Market, Segmentation By Analysis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Quality Control Market

• 27.1. Brazil Pharmaceutical Quality Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pharmaceutical Quality Control Market, Segmentation By Deployment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pharmaceutical Quality Control Market, Segmentation By Analysis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Quality Control Market

• 28.1. Middle East Pharmaceutical Quality Control Market Overview
• 28.2. Middle East Pharmaceutical Quality Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pharmaceutical Quality Control Market, Segmentation By Deployment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pharmaceutical Quality Control Market, Segmentation By Analysis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Quality Control Market

• 29.1. Africa Pharmaceutical Quality Control Market Overview
• 29.2. Africa Pharmaceutical Quality Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pharmaceutical Quality Control Market, Segmentation By Deployment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pharmaceutical Quality Control Market, Segmentation By Analysis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Quality Control Market Competitive Landscape And Company Profiles

• 30.1. Pharmaceutical Quality Control Market Competitive Landscape
• 30.2. Pharmaceutical Quality Control Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Quality Control Market Other Major And Innovative Companies

• 31.1. McKinsey And Company Inc.
• 31.2. SGS S.A.
• 31.3. Eurofins Scientific SE
• 31.4. WuXi AppTec Co. Ltd.
• 31.5. Charles River Laboratories International Inc.
• 31.6. PerkinElmer Inc.
• 31.7. Mettler-Toledo International Inc.
• 31.8. bioMerieux SA
• 31.9. Shimadzu Scientific Instruments Inc.
• 31.10. Waters Corporation
• 31.11. Randox Laboratories Ltd.
• 31.12. SOLVIAS AG
• 31.13. Esco Micro Pte. Ltd
• 31.14. REMI Elektrotechnik Limited
• 31.15. Lucideon Limited

32. Global Pharmaceutical Quality Control Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Quality Control Market

34. Recent Developments In The Pharmaceutical Quality Control Market

35. Pharmaceutical Quality Control Market High Potential Countries, Segments and Strategies

• 35.1 Pharmaceutical Quality Control Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pharmaceutical Quality Control Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pharmaceutical Quality Control Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer